Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/30450
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMUNDIM, F.
dc.contributor.authorFRANCO, A.
dc.contributor.authorINFANTE, K.
dc.contributor.authorNETO, J.
dc.contributor.authorBRENTANI, M. M.
dc.contributor.authorFACINA, G.
dc.contributor.authorWAITZBERG, A.
dc.date.accessioned2019-01-29T17:08:40Z-
dc.date.available2019-01-29T17:08:40Z-
dc.date.issued2018
dc.identifier.citationVIRCHOWS ARCHIV, v.473, suppl.1, p.S209-S209, 2018
dc.identifier.issn0945-6317
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/30450-
dc.language.isoeng
dc.publisherSPRINGEReng
dc.relation.ispartofVirchows Archiv
dc.rightsrestrictedAccesseng
dc.titleCan neoadjuvant chemotherapy change clinic pathological and survival parameters in HER-2 positive breast cancer patients?eng
dc.typeconferenceObjecteng
dc.rights.holderCopyright SPRINGEReng
dc.subject.wosPathologyeng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalMUNDIM, F.:Univas Brazil, Pathol, Pouso Alegre, Brazil
hcfmusp.description.beginpageS209
hcfmusp.description.endpageS209
hcfmusp.description.issuesuppl 1
hcfmusp.description.volume473
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000443414102377
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
dc.description.indexMEDLINEeng
dc.identifier.eissn1432-2307
Appears in Collections:

Comunicações em Eventos - FM/MDR
Departamento de Radiologia - FM/MDR

Comunicações em Eventos - LIM/24
LIM/24 - Laboratório de Oncologia Experimental


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.